Syapse Stock
Real-World Evidence Company
Sign up today and learn more about Syapse Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Syapse Stock
Syapse works with health systems to implement precision medicine programs across their organizations, enabling oncologists to deliver personalized care to every patient who needs it.
Investors
Amgen Ventures
Ascension Ventures
GE Ventures
View, Pivotal, Virgin Hyperloop One, Omada Health, Desktop Metal, Rethink Robotics, Catalant, Vineti, Syapse, Tamr
Intermountain Healthcare Innovation Fund
Medidata Solutions
Roche Venture Fund
Social Capital
Slack, Relativity Space, Netskope, Box, BetterUp, Greenlight, Guild Education, Flutterwave, Palmetto Clean Technology, Groq
Social Capital Partners
Funding History
| January 2011 | $1.6M |
|---|---|
| January 2013 | $3.0M |
| July 2014 | $10.0M |
| January 2016 | $25.0M |
| November 2017 | $30.0M |
| January 2019 | $20.0M |
| May 2020 | $30.0M |
Management
Chief Executive Officer
Ken Tarkoff
Chief Financial Officer
Fletcher Payne
Chief Technology Officer
Tony Loeser
Press
biospace - Oct, 6 2021
Syapse Enters Real-World Data Collaboration with Merck to Inform and Improve Cancer Caresyapse - Nov, 15 2020
AdventHealth Joins Syapse’s Learning Health Network to Launch a Collaboration to Advance Cancer Caresyapse - Sep, 9 2020
Syapse Learning Health Network delivers real-world data insights to enable the AMITA Health Cancer Institute to provide high-quality patient-centered careEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
